CRISPR/Cas9-Induced DNA Damage Enriches for Mutations in a p53-Linked Interactome: Implications for CRISPR-Based Therapies

por Jiang, Long, Ingelshed, Katrine, Shen, Yunbing, Boddul, Sanjaykumar V., Iyer, Vaishnavi Srinivasan, Kasza, Zsolt, Sedimbi, Saikiran, Lane, David P., Wermeling, Fredrik
Publicado 2022

MDM2 inhibitors, nutlin-3a and navtemadelin, retain efficacy in human and mouse cancer cells cultured in hypoxia

por Lerma Clavero, Ada, Boqvist, Paula Lafqvist, Ingelshed, Katrine, Bosdotter, Cecilia, Sedimbi, Saikiran, Jiang, Long, Wermeling, Fredrik, Vojtesek, Borivoj, Lane, David P., Kannan, Pavitra
Publicado 2023

Combined proinflammatory cytokine and cognate activation of invariant natural killer T cells enhances anti-DNA antibody responses

por Sedimbi, Saikiran K., Hägglöf, Thomas, Garimella, Manasa G., Wang, Shan, Duhlin, Amanda, Coelho, Ana, Ingelshed, Katrine, Mondoc, Emma, Malin, Stephen G., Holmdahl, Rikard, Lane, David P., Leadbetter, Elizabeth A., Karlsson, Mikael C. I.
Publicado 2020

CD11c-CD8 Spatial Cross Presentation: A Novel Approach to Link Immune Surveillance and Patient Survival in Soft Tissue Sarcoma

por Su, Yanhong, Tsagkozis, Panagiotis, Papakonstantinou, Andri, Tobin, Nicholas P., Gultekin, Okan, Malmerfelt, Anna, Ingelshed, Katrine, Neo, Shi Yong, Lundquist, Johanna, Chaabane, Wiem, Nisancioglu, Maya H., Leiss, Lina W., Östman, Arne, Bergh, Jonas, Sedimbi, Saikiran, Lehti, Kaisa, Lundqvist, Andreas, Stragliotto, Christina L., Haglund, Felix, Ehnman, Monika
Publicado 2021

The MDM2 Inhibitor Navtemadlin Arrests Mouse Melanoma Growth In Vivo and Potentiates Radiotherapy

por Ingelshed, Katrine, Spiegelberg, Diana, Kannan, Pavitra, Påvénius, Linnéa, Hacheney, Jessica, Jiang, Long, Eisinger, Silke, Lianoudaki, Danai, Lama, Dilraj, Castillo, Francisca, Bosdotter, Cecilia, Kretzschmar, Warren W., Al-Radi, Omayma, Fritz, Nicolas, Villablanca, Eduardo J., Karlsson, Mikael C. I., Wermeling, Fredrik, Nestor, Marika, Lane, David P., Sedimbi, Saikiran K.
Publicado 2022